A merger between Valeant Pharmaceuticals International Inc and Allergan Inc would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday. Valeant will finalize and announce terms of its proposal shortly, the spokesperson said.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 6.03% or $8.08/share to $142.00. In the past year, the shares have traded as low as $81.33 and as high as $134.41. On average, 2944310 shares of AGN exchange hands on a given day and today's volume is recorded at 10449715.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.24% or $3.96/share to $126.01. In the past year, the shares have traded as low as $71.97 and as high as $153.10. On average, 1972590 shares of VRX exchange hands on a given day and today's volume is recorded at 2756120.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.21% or $4.31/share to $138.76. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 377123 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 318584.
Source
